Home/Filings/4/0001213900-24-069038
4//SEC Filing

Townsend John 4

Accession 0001213900-24-069038

CIK 0001766140other

Filed

Aug 13, 8:00 PM ET

Accepted

Aug 14, 4:15 PM ET

Size

5.3 KB

Accession

0001213900-24-069038

Insider Transaction Report

Form 4
Period: 2024-08-12
Townsend John
Chief Financial Officer
Transactions
  • Award

    Stock Options

    2024-08-12+40,256915,565 total
    Exercise: $0.34Exp: 2034-08-12Common Stock (40,256 underlying)
Footnotes (1)
  • [F1]10,064 of the stock options vest on August 12, 2025 and 1/36th of the remaining options vest at the end of each successive month thereafter.

Documents

1 file

Issuer

Unicycive Therapeutics, Inc.

CIK 0001766140

Entity typeother

Related Parties

1
  • filerCIK 0001511906

Filing Metadata

Form type
4
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 4:15 PM ET
Size
5.3 KB